Can Hormone Imbalance Cause Infertility?
For couples trying to conceive, a diagnosis of infertility or unexplained difficulty getting pregnant can be emotionally devastating. Hormonal imbalances are among the most common underlying causes — and crucially, among the most treatable. Understanding which hormonal conditions affect fertility, what testing reveals, and when to seek expert medical support can make a meaningful difference in outcomes.
Polycystic Ovary Syndrome (PCOS) and Fertility
Polycystic ovary syndrome is the most common hormonal cause of female infertility, affecting an estimated eight to thirteen percent of reproductive-age women. PCOS involves a combination of elevated androgens (testosterone and DHEA), insulin resistance, and disrupted hypothalamic-pituitary signaling that prevents the normal hormonal cascade required for follicle maturation and ovulation. Without regular ovulation, conception cannot occur through natural timing.
The severity of PCOS-related fertility impairment varies considerably. Some women with PCOS ovulate infrequently but predictably and can conceive with careful cycle monitoring and lifestyle modification. Others require medical ovulation induction. Critically, insulin resistance — present in 50 to 80 percent of women with PCOS — is a major driver of the condition, and strategies that improve insulin sensitivity (dietary changes, exercise, and in some cases metformin) can restore more regular ovulation and meaningfully improve fertility outcomes.
Thyroid Disorders and Fertility
Thyroid dysfunction is the second most common hormonal cause of female infertility and is frequently overlooked in standard fertility workups that do not include thyroid testing. Hypothyroidism — even in its subclinical form — disrupts the hypothalamic-pituitary-ovarian axis, causing irregular or anovulatory cycles, elevated prolactin levels, and reduced endometrial receptivity. It also increases the risk of early miscarriage, as adequate thyroid hormone is essential for normal early fetal development before the fetal thyroid becomes functional.
Autoimmune thyroid disease (Hashimoto's thyroiditis) is particularly relevant to fertility because thyroid antibodies themselves are associated with implantation failure and recurrent miscarriage, independent of thyroid hormone levels. Women with recurrent pregnancy loss should be tested for thyroid antibodies even if their TSH appears normal. Optimizing thyroid function before and during early pregnancy significantly reduces fertility and miscarriage risk related to thyroid disorders.
Progesterone Deficiency and the Luteal Phase
Progesterone is essential for preparing the uterine lining (endometrium) for implantation and for maintaining early pregnancy. After ovulation, the corpus luteum — the remnant of the follicle that released the egg — produces progesterone during the luteal phase of the menstrual cycle. If progesterone levels are insufficient, the endometrium does not mature properly, making implantation less likely. This is called luteal phase deficiency.
Luteal phase deficiency may present as a short second half of the menstrual cycle (less than ten days from ovulation to menstruation), spotting before the expected period, or a history of early miscarriage. Progesterone supplementation in the luteal phase — using bioidentical progesterone — is a common and effective intervention for women with documented luteal phase deficiency who are trying to conceive.
Other Hormonal Contributors to Infertility
Elevated prolactin (hyperprolactinemia) — caused by pituitary adenomas, thyroid dysfunction, certain medications, or chronic stress — suppresses GnRH and LH production, disrupting ovulation. Elevated FSH levels indicate diminished ovarian reserve and reflect a reduction in the number of remaining follicles. AMH (anti-Müllerian hormone) provides a quantitative measure of ovarian reserve and is an important component of fertility testing in women over 35. Adrenal androgen excess from congenital adrenal hyperplasia or adrenal dysfunction can also suppress ovulation and impair fertility.
The Testing Protocol for Hormonal Fertility Evaluation
A comprehensive hormonal fertility evaluation in women typically includes FSH and LH (drawn on day 2 to 4 of the menstrual cycle), estradiol, AMH, progesterone (drawn 7 days after confirmed ovulation), TSH, Free T4, thyroid antibodies, prolactin, fasting insulin and glucose, total and free testosterone, and DHEA-S. This panel, combined with pelvic ultrasound to assess ovarian follicle count and uterine anatomy, provides the information needed to identify and address hormonal contributors to infertility.
When to See a Specialist
Women under 35 are generally advised to seek evaluation after 12 months of unprotected intercourse without conception; women over 35 should seek evaluation after 6 months. Women with known hormonal conditions (PCOS, thyroid disease, irregular cycles, prior miscarriage) benefit from evaluation before actively trying to conceive so that hormonal optimization can be achieved in advance.
Dr. Kenton Bruice MD offers comprehensive hormonal evaluation and individualized bioidentical hormone therapy at his practices in Denver, Aspen, and St. Louis. If you are experiencing difficulty conceiving and suspect a hormonal imbalance may be contributing, we encourage you to schedule a consultation with Dr. Bruice to get a thorough assessment and personalized treatment plan.